by Truveta staff | Sep 15, 2025 | Research
Gestational diabetes is one of the most common complications of pregnancy, affecting roughly 5–9% of pregnancies in the United States. When diagnosed and managed early, patients can avoid complications such as high birth weight, preterm delivery, or cesarean section....
by Truveta staff | Sep 12, 2025 | Data
Non–small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases and remains the leading cause of cancer death worldwide. While major advances in targeted therapies and immunotherapies have transformed care, gaps persist in biomarker testing, treatment...
by Truveta staff | Aug 25, 2025 | Data
Multiple sclerosis (MS) affects approximately 1 million people in the United States, with women representing nearly 75% of patients. Over the past decade, consensus guidelines from leading MS experts have increasingly emphasized the importance of early intervention...
by Truveta staff | Sep 11, 2024 | Research
The overall trends of hospitalizations associated with viral gastroenteritis – norovirus and rotavirus – show a steady decrease over the last few months, leading to a rate of 0.04% in August 2024 in the overall population. However, we see first indicators that the...
by Truveta News | Sep 4, 2024 | News
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has partnered with Truveta to use its electronic health record (EHR) data to drive comparative, cost-effectiveness, and outcomes research....
